You are here

SARC022

Completed
A Phase 2 Study of Linsitinib (OSI-906) in Pediatric and Adult Wild Type Gastrointestinal Stromal Tumors
Type of Sarcoma: 
Gastrointestinal stromal tumors
Drug: 
OSI-906
Accrual Status: 
Completed
Overall Study Principal Investigator: 

Margaret von Mehren, MD
Fox Chase Cancer Center

For more information about this trial and open sites: